drugset / Trial / NCT02564497
A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C
RandomizedParallel-groupOpen-labelOther
Summary
The purpose of the study is to compare the Pharmacokinetics (PK) of Process E belatacept relative to Process C belatacept in Healthy subjects
Timeline
- Start
- 2015-10-02
- Primary completion
- 2017-01-27
- Completion
- 2017-01-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Belatacept | Protein / enzyme biologic | — | — |
Indications
No indication recorded.